Trial intelligence / Profile preview

Propofol Cardioprotection for Type II Diabetics

NCT00734383Phase 3Completed

Sponsor
University of British Columbia
Start
Apr 2005
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propofol injection (veterinary) in Myocardial injury, sponsored by University of British Columbia. Started Apr 2005; status: completed.

02

Drugs

propofol injection (veterinary)
03

Conditions

Myocardial injury

Beyond the preview

Go deeper on NCT00734383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00734383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call